10 August 2020 | News
Trivitron Healthcare offers a comprehensive range of ICMR approved COVID-19 solutions
Image credit- shutterstock.com
Chennai based company Trivitron Healthcare is pleased to announce the launch of a full suite of indigenously developed COVID-19 Testing products, as the organization’s contribution towards Atmanirbhar (self-reliant) Bharat.
Trivitron Healthcare offers a comprehensive range of ICMR approved COVID-19 solutions including RT-PCR Tests (COVIDsure&COVIDsure Pro), RNA Extraction kits (RNAsure), Viral Transport Media (ViSure), Total Antibody ELISA Test (COVIDscreen Plus) and ELISA IgG (COVID Kavach IgG) testing kits for Covid-19.
Realizing the enormous need of testing kits in the domestic market, to address this, the organization has indigenously designed & developed, and had started large scale manufacturing for COVID-19 RT‑PCR test kits, RNA Extraction kits, Viral Transport Media, ELISA Antibody Tests, and will soon be launching Rapid POC Tests as well, for the Indian market. Trivitron is committed to manufacturer cost-effective and globally-accepted high-quality kits, and other COVID-19 solutions.
“We have been focused on making world-class Made-in-India medical technology solutions for domestic and global markets. The current situation of COVID-19 pandemic demanded innovation in developing indigenous and economical testing kits for the Indian market and we have responded to this. We have a complete range of COVID testing portfolio which will enable scaling up of current testing needs of the Indian & International Healthcare Ecosystem.’’ said, Dr. GSK Velu, Chairman and Managing Director, Trivitron Healthcare.